Lebertoxika

Lebertoxika is a hypothetical hepatotoxic agent used in toxicology and pharmacology to illustrate mechanisms of liver injury. The term is not the name of a specific chemical, but rather a conceptual label for a toxin with liver-specific effects.

In textbooks and coursework, Lebertoxika may refer to a class of reactive metabolites produced during hepatic metabolism of various compounds, or to endogenous species under oxidative stress that can bind hepatic proteins.

Its hepatotoxic effects are proposed to arise from mitochondrial dysfunction, oxidative stress, covalent protein modification, and interference with bile acid transporters. These pathways can produce centrilobular necrosis and steatosis in experimental models.

In simulated clinical scenarios, exposure yields elevated aminotransferases (ALT, AST), jaundice, and, on histology, hepatocellular necrosis. Diagnosis is hypothetical; biomarkers are used in teaching to reveal general principles of DILI.

Due to its fictional nature, there is no real antidote; management mirrors general DILI principles: discontinue exposure, supportive care, and monitoring. Lebertoxika remains a teaching tool to compare mechanisms of hepatic injury across drugs and chemicals.